A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
The most common questions that we get here at Altered States Integration are about the practical use of psychedelics. Many people are already excited about the potential therapeutic benefits and understand enough about entheogens to want to conduct their own DIY...
In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants...
Dr. Carl Hart’s argument that we should de stigmatize, legalize, and regulate all drugs is revolutionary for two main reasons. For one, he is an internationally lauded neuroscientist and neuropsychopharmacologist, and one of the world’s leading experts on drug use,...
